Bin There Dump That Northern Ontario Honoured with Local Business Awards
NORTH BAY, Ontario–(BUSINESS WIRE)–Bin There Dump That, a trusted residential dumpster rental provider, is proud to announce that its Northern Ontario... Read more.
Healthcare CMO Market Analysis Report 2025: Ongoing R&D Investments and Launch of Novel, Regulatory-Approved Contract Manufacturing Solutions – Forecast to 2029 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Healthcare CMO Market: 2025 Edition” report has been added to ResearchAndMarkets.com’s offering. The global... Read more.
Positive Safety and Efficacy of NI-1801 in Platinum Resistant Ovarian Cancer Patients Presented in Proffered Paper Oral Presentation at ESMO 2025
GENEVA–(BUSINESS WIRE)–Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to treat... Read more.
EOT.AI Accelerates Industrial AI by Joining the Databricks Partner Program
DENVER–(BUSINESS WIRE)–EOT.AI, a leading provider of AI-powered solutions for industrial enterprises, today announced that its flagship product, Twin... Read more.
Cooler Master Expands Its Thermal Excellence with Hyper 212 3DHP Series and V4 Alpha 3DHP Black
Reliable, Quiet Single-Tower Air Coolers Built on Patented 3DHP CITY OF INDUSTRY, Calif.–(BUSINESS WIRE)–#3DHPtechnology–Cooler Master, a global... Read more.
BeOne Medicines Presents New Data on TEVIMBRA in Lung Cancer at ESMO 2025
New data from two pivotal TEVIMBRA studies – RATIONALE-307 and -312 – reinforce the PD-1 inhibitor’s proven clinical benefit in both NSCLC and ES-SCLC Early... Read more.
Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference
EL MONTE, Calif.–(BUSINESS WIRE)–Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established... Read more.
USANA Updates the Timing of the Release of Third Quarter 2025 Earnings Release and Conference Call
SALT LAKE CITY–(BUSINESS WIRE)–USANA Health Sciences, Inc. (NYSE:USNA) (“the Company,” “USANA”) today announced that it has updated the timing... Read more.
SunRock Biopharma and Chime Biologics Announce Strategic Collaboration to Advance Development of Anti-CCR9 Antibody SRB5
SANTIAGO, Spain & WUHAN, China–(BUSINESS WIRE)–SunRock Biopharma, a biotechnology company focused on developing next-generation therapeutic antibodies,... Read more.
CatalYm Presents Long-Term Phase 1/2a Data Confirming Sustained Responses with Visugromab in CPI-Refractory Tumors at ESMO 2025
Median duration of response exceeded 32 months in non-squamous non-small cell lung cancer (nsqNSCLC), 28 months in urothelial cancer (UC) and 19 months in hepatocellular... Read more.